Others Products Targets
- Voltage-gated Sodium (NaV) Channel (30)
- Voltage-gated Potassium (KV) Channel (38)
- Voltage-gated Calcium Channel (CaV) (38)
- TRPV (30)
- NFKB and IKB (30)
- GABAB Receptor (28)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Bradykinin Receptor (12)
- Others (20)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- IRAK (1)
- NK2 Receptor (7)
- NK1 Receptor (15)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- NK3 Receptor (5)
- NMDA Receptor (87)
- Kainate Receptor (22)
- CCK2 Receptor (7)
- CCK1 Receptor (3)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Delta opioid receptor (16)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Others - Page 71
- Cat.No. Product Name Information/Activity
-
BCC7506
BYK 191023 dihydrochloride
Potent and selective inhibitor of iNOS
-
BCC6824
EIT hydrobromide
1071-37-0
-
BCC6862
2-Iminopiperidine hydrochloride
16011-96-4
-
BCC6837
S-Isopropylisothiourea hydrobromide
4269-97-0
-
BCC6791
(S)-Methylisothiourea sulfate
867-44-7
-
BCC5706
L-NIL hydrochloride
150403-89-7
-
BCC7057
1400W dihydrochloride
1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
-
BCC7647
ARL 17477 dihydrochloride
866914-87-6
-
BCC6770
3-Bromo-7-nitroindazole
3-Bromo-7-nitroindazole is a more potent and selective inhibitor of neuronal nitric oxide synthase (nNOS) than eNOS or inducible nitric oxide synthase (iNOS). 3-Bromo-7-nitroindazole affects the intercellular messenger nitric oxide (NO) synthesis throughout the body and brain.
-
BCC6965
Nω-Propyl-L-arginine hydrochloride
137361-05-8


